cgt - i found that reference too.
The thing that I think makes it not a good comparison for our situation is that it refers to "households". . . ..which may contain several members.
Therefore, the rate of infection of individuals is likely to be much less than 19 per cent. . . . just as the proportion of individuals treated with zanamivir who contracted influenza is likely to be less than 4 per cent.
- Forums
- ASX - By Stock
- BTA
- Ann: Phase III prophylaxis trial for CS-8958
Ann: Phase III prophylaxis trial for CS-8958 , page-35
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online